NCT02113033View on ClinicalTrials.gov

VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 7, 2014

Primary Completion Date

February 22, 2016

Study Completion Date

September 20, 2016

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DEVICE

Equilia® Vagal Nerve Stimulation

Vagal Nerve Stimulation synchronized with cardiac activity

Trial Locations (6)

1200

UCL St Luc, Brussels

11040

Dedinje Cardiovascular Institute, Belgrade

31059

CHU Rangueil, Toulouse

35033

CHRU Hôpital Pontchaillou, Rennes

75015

Hôpital Européen Georges Pompidou, Paris

0027

Rikshospitalet, Oslo

Sponsors

Lead Sponsor

LivaNova
All Listed Sponsors
lead

LivaNova

INDUSTRY

NCT02113033 - VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients | Biotech Hunter | Biotech Hunter